Polyclonal Rabbit anti‑Human FSCN1 / Fascin Antibody (Biotin, aa277‑396, WB) LS‑C686292
Polyclonal Rabbit anti‑Human FSCN1 / Fascin Antibody (Biotin, aa277‑396, WB) LS‑C686292
Antibody:
FSCN1 / Fascin Rabbit anti-Human Polyclonal (aa277-396) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
FSCN1 / Fascin Rabbit anti-Human Polyclonal (aa277-396) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
Fascin antibody LS-C686292 is a biotin-conjugated rabbit polyclonal antibody to human Fascin (FSCN1) (aa277-396). Validated for WB.
Target
Human FSCN1 / Fascin
Synonyms
FSCN1 | 55 kDa actin-bundling protein | Fascin | HSN | Singed-like protein | SNL | p55
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant FSCN (Gln277-Gly396) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against FSCN.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Flow Cytometry
Reactivity:
Rat
Range:
0.78-50 ng/ml
Reactivity:
Mouse
Range:
5-100 ng/ml
Reactivity:
Rat
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
62.5-4000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/17/2024